"I have always been genuinely fascinated by the search for the developmental origins of individual differences in brain development and function," said Dr Meaney, whose work has earned him election to ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

With the validation of the service in Nepal, doctors no longer need to send specimens of suspected breast cancer patients to ...

Personal guides to well-being are becoming increasingly possible because of new and sophisticated genome-wide technologies ...

TORONTO, Ontario, Canada, 31 December 2024 - In a comprehensive Genomic Press Interview, leading geneticist Dr. Cathy Barr unveils crucial discoveries ...

Investors continued to sell off shares in Sangamo Therapeutics Inc. (NASDAQ:SGMO) before market open on Tuesday following ...

MONTREAL, Quebec, Canada, 31 December 2024 - In a comprehensive Genomic Press Interview, renowned neuroscientist Dr. Michael ...

Medical researcher Fayzan Rab combines clinical expertise with tech industry experience to investigate the economic and ...

Distinguished McGill University Professor Emeritus Dr. Michael Meaney shares groundbreaking insights into how environmental ...

Mount Sinai researchers discovered that harmine, a beta cell regenerative drug, may transform alpha cells into beta cells, ...

The patient in Louisiana who was hospitalized with severe bird flu illness was found to have a mutated version of the virus.

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Chronic Lymphocytic Leukemia (CLL).